To validate the results obtained in peripheral cells from ALS patients, we tested the effects of Tideglusib in a neuronal cell model of induced TDP-43 phosphorylation by ethacrynic acid (EA) treatment [29]. Here, TARDBP is linked to amyotrophic lateral sclerosis.